Sergio Arevalo-Rodriguez

Av. Joan XXIII, 27-31
Barcelona, CT 08028, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Water Networks as Hydrophobic Recognition Motifs in Proteins.

Water Networks as Hydrophobic Recognition Motifs in Proteins.

Journal: Angewandte Chemie (International ed. in English)

Published: September 25, 2025

Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease.

Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease.

Journal: Pharmaceutics

Published: August 04, 2023

Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space.

Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space.

Journal: Journal of medicinal chemistry

Published: December 13, 2021

Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease.

Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: February 23, 2021

Synthesis, Characterization and HPLC Analysis of the (1S,2S,5R)-Diastereomer and the Enantiomer of the Clinical Candidate AR-15512.

Synthesis, Characterization and HPLC Analysis of the (1S,2S,5R)-Diastereomer and the Enantiomer of the Clinical Candidate AR-15512.

Journal: Molecules (Basel, Switzerland)

Published: December 30, 2020

Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil.

Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil.

Journal: British journal of pharmacology

Published: December 17, 2020

Correction to Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Correction to Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: September 14, 2020

Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5.

Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5.

Journal: Pharmaceutics

Published: April 24, 2020

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease.

Journal: Journal of medicinal chemistry

Published: March 10, 2020

I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway.

I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway.

Journal: GeroScience

Published: December 16, 2019

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca2.

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca2.

Journal: Cells

Published: November 23, 2019

Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.

Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 22, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026